Agile Therapeutics, Inc. (AGRX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 02:38PM EST. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 76.46M |
| Enterprise Value | 78.19M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 16.88 |
| Price/Book (mrq) | 7.16 |
| Enterprise Value/Revenue | 23.44 |
| Enterprise Value/EBITDA | -1.23 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.99 |
| 52-Week Change 3 | -75.57% |
| S&P500 52-Week Change 3 | 27.61% |
| 52 Week High 3 | 3.7700 |
| 52 Week Low 3 | 0.5400 |
| 50-Day Moving Average 3 | 0.7697 |
| 200-Day Moving Average 3 | 1.3547 |
Share Statistics
| Avg Vol (3 month) 3 | 2.09M |
| Avg Vol (10 day) 3 | 2.84M |
| Shares Outstanding 5 | 121.4M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 98.53M |
| % Held by Insiders 1 | 1.04% |
| % Held by Institutions 1 | 34.60% |
| Shares Short (Nov. 14, 2021) 4 | 1.44M |
| Short Ratio (Nov. 14, 2021) 4 | 0.59 |
| Short % of Float (Nov. 14, 2021) 4 | 1.39% |
| Short % of Shares Outstanding (Nov. 14, 2021) 4 | 1.19% |
| Shares Short (prior month Oct. 14, 2021) 4 | 1.43M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec. 30, 2020 |
| Most Recent Quarter (mrq) | Sep. 29, 2021 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -1,960.07% |
Management Effectiveness
| Return on Assets (ttm) | -64.82% |
| Return on Equity (ttm) | -180.07% |
Income Statement
| Revenue (ttm) | 3.34M |
| Revenue Per Share (ttm) | 0.04 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 467k |
| EBITDA | -63.61M |
| Net Income Avi to Common (ttm) | -69.16M |
| Diluted EPS (ttm) | -0.7740 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.73M |
| Total Cash Per Share (mrq) | 0.12 |
| Total Debt (mrq) | 16.47M |
| Total Debt/Equity (mrq) | 154.22 |
| Current Ratio (mrq) | 2.27 |
| Book Value Per Share (mrq) | 0.11 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -65.93M |
| Levered Free Cash Flow (ttm) | -41.82M |
